MS Dhoni’s investments include sports tech, fitness brands, and a production house. Sachin Tendulkar has a venture fund. Virat Kohli owns a fashion brand and a gym chain. Indian cricketers are no longer just athletes—they are business moguls. This article profiles how cricketers are building lasting wealth beyond the pitch.
In just one month, ECLGS 5.0 issued guarantees covering nearly ₹50,000 crore in loans. The government is factoring in potential credit losses of 6-8 per cent—double the rate of previous versions. This is not a normal bailout. This is a wartime measure against an economic siege. But when the war ends, the debt remains.
Indian companies are sitting on record profits and record cash reserves. But instead of building factories at home or acquiring assets abroad, they are doing something unexpected: nothing. The 49% crash in outward FDI is not just about geopolitics. It is a quiet vote of no confidence in the very market where they made their fortunes.
The old playbook said bonds hedge equities in a crisis. The Iran war shattered that assumption. As Trump ordered strikes on Iranian "critical facilities," both stocks and bonds fell together—while swaption straddles surged. This is not your grandfather's geopolitical risk. The rules have changed.
When the Strait of Hormuz closes, a garment factory in Bangladesh doesn't just pay more for fuel. It shuts down. A food processor in Kenya doesn't just see higher shipping costs. It lays off its all-female workforce. Geopolitics is not gender-neutral. And the women who run the world's most vulnerable supply chains are paying the price.
In the West, the conversation about women in business begins with venture capital and ends with the funding gap. In India, a parallel economy is quietly creating crores of women entrepreneurs without waiting for a single term sheet. The Lakhpati Didi programme is not charity. It is a market correction happening one self-help group at a time.
While the world debates whether ESG investing is dead, Adesuwa Okunbo-Rhodes is writing a different story. Her firm, Aruwa Capital Management, has built a track record that attracted institutional investors—including pension funds and development finance institutions—to a market most global funds avoid. The final countdown is not about survival. It is about scaling what works.
Immuneel Therapeutics' ₹100 crore Series B round highlights growing investor confidence in India's ability to develop advanced cell and gene therapies rather than simply manufacture healthcare products.
As AI infrastructure expands rapidly, growing concerns about water consumption are raising questions about whether natural resources could become one of the industry's biggest long-term constraints.
Applied Digital's $5.2 billion AI data-center lease highlights how infrastructure providers are becoming some of the most important beneficiaries of the artificial-intelligence boom